BioSpace News Archive

CloudLIMS, a leading laboratory data management informatics provider, announces the release of the Training Module for its Laboratory Information Management System, CloudLIMS.

Toujeo® improved blood sugar control vs insulin degludec in adults with type 2 diabetes and moderate-to-severe kidney impairment • Secondary analyses expand results from BRIGHT head-to-head clinical trial

Molecular Health, a leading company in the field of data science for precision medicine and specializing in the development of products and services leveraging its proprietary biomedicine technology platform Dataome, is due to participate in several upcoming conferences between September and December, 2019.

A new study has shown the power of genetic testing to pick out the best drugs for children with cancer to extend and improve their lives – signalling a new era of precision medicine for young patients.

Switching to Toujeo® in a real-world setting produced a 27% reduction in risk of low blood sugar requiring an emergency department visit in patients at high risk ∙ New analyses extend DELIVER and LIGHTNING Real-World Evidence programs

An industry first, the volunteer committee will evaluate unique patient needs and advise PRA on how clinical trials can be adapted for rare disease patients

Aiming to Expand Availability of Eribulin to Patients in India with Two Brands Halaven and Teceris

Fujitsu Limited and PeptiDream Inc. has announced that they have agreed to initiate joint research and development in the area of peptide drug discovery, using Fujitsu’s Digital Annealer, which employs next-generation computing architecture to quickly solve combinatorial optimization problems.

Owkin announces that Dr Gilles Wainrib, Co-founder and Chief Scientific Officer at Owkin, will present at the special session on Artificial Intelligence at the European Society for Medical Oncology Congress 2019 in Barcelona, Spain on Saturday, September 28, 2019.

APEX Biologix, a nationally recognized leader in manufacturing and distributing cutting-edge biologic supplies will now have access to an exciting new product.